share_log

盘中速览 | 港股冲高回落,恒指跌近1%;博彩股逆市上扬,美高梅中国涨超5%

Midday Snapshot | Hong Kong stocks rise and fall, Hang Seng index falls nearly 1%; Macau casino stocks rise against the trend, MGM China up more than 5%.

Futu News ·  10:41

Futu News August 5th, the Hong Kong stock market opened lower today, and then experienced a brief rise before falling back. As of press time,$Hang Seng Index (800000.HK)$down 0.91%,$Hang Seng China Enterprises Index (800100.HK)$down 1.13%,$Hang Seng TECH Index (800700.HK)$down 0.72%.

In terms of sectors, macau casino stocks bucked the trend and rose, with MGM China rising more than 5%, Sands China Ltd rising nearly 4%, Paradise Ent and Galaxy Ent rising more than 2%.

Some biomedical stocks rose, with Beigene up nearly 5%, Tigermed up more than 4%, Remegen up nearly 4%, and Genscript Bio up nearly 3%.

Mainland real estate stocks rose across the board, with Agile Group up more than 3%, Shimao Group up nearly 3%, and Radiance Hldgs up more than 2%.

Cryptocurrency spot ETFs plummeted, with Bosera Ethereum, Huaxia Ethereum, and Jiashi Ethereum falling by more than 27%, while Jiashi Bitcoin and Bosera Bitcoin fell nearly 16%.

Petroleum stocks weakened, with CNOOC falling nearly 5%, PetroChina falling nearly 4%, and China Oilfield falling nearly 3%.

In terms of individual stocks,$XIABUXIABU (00520.HK)$After issuing a warning, it fell more than 6%, with a projected net loss of over 0.26 billion yuan in the first half of the year and a provision for impairment of approximately 0.2 billion yuan due to store closures.

$CHINA RE (01508.HK)$up nearly 10%, with an expected year-on-year increase of about 150% to 200% in its net profit attributable to the owner of the parent in the first half of the year.

$Highlife Medical (02407.HK)$ After issuing a warning, it fell nearly 12%, and is expected to see a year-on-year decrease of about 74.5% to 76.8% in its net profit in the first half of the year.

$LEPU BIO-B (02157.HK)$rose nearly 6%, and its candidate drug MRG003 has been granted breakthrough therapy designation by the FDA.

$COMBA (02342.HK)$fell more than 10%, and is expected to achieve a loss attributable to shareholders of no more than 0.16 billion Hong Kong dollars in the mid-term.

$AJISEN (CHINA) (00538.HK)$After issuing a warning, it fell more than 19%, with an expected loss attributable to shareholders of 20 million yuan in the mid-term.

Editor/Lambor

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment